Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Letclas Tablet

Prescription Icon
Prescription Required

Marketer

Gleason Healthcare

Salt Composition

Letrozole (2.5mg)

Overview Letclas Tablet

Post-menopausal women with breast cancer may find relief with Letclas Tablets. This medication can be a standalone treatment or used alongside other therapies like surgery or radiotherapy. It's also indicated for advanced breast cancer, aiming to curb metastasis. Letclas Tablets can be administered with or without food, always following the physician's prescribed dosage and duration for optimal results. Dosage varies based on the specific treatment plan; your doctor will tailor the regimen to your needs. Continuous use, as directed, is crucial. Common side effects include hot flushes, tiredness, excessive sweating, and elevated cholesterol. Report any concerning symptoms to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you're currently using, as interactions may occur. Disclose pregnancy or breastfeeding status. Your physician may order blood tests to monitor vitamin D levels and bone density throughout the treatment period.

Uses of Letclas Tablet

Managing Breast Cancer

Major Benefits of Letclas Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Letclas Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, however, consistent timing is recommended.

Common Side effects of Letclas Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letclas Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Letclas Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Letclas Tablet can be taken with or without food, consistency is key—take it at the same time each day.

How Letclas Tablet works:

Letclas tablets function as an aromatase inhibitor, reducing the body's estrogen production—a key female hormone. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Letclas Tablet's concurrent use with alcohol presents no known adverse reactions.

PregnancyPregnancyUNSAFE

Using Letclas Tablet during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in both animals and pregnant humans indicates substantial risks to fetal development.

Breast feedingBreast feedingUNSAFE

Lactation and Letclas Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Letclas Tablets might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Renal impairment does not necessitate dosage alteration for Letclas Tablet, which is considered safe in such patients. Nevertheless, data regarding its use in end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Letclas Tablet judiciously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Letclas Tablet :

Should you forget a Letclas Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Letclas Tablet

LabelValue
Chemical Type Diphenylmethane compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Letclas Tablet

Letclas Tablet, an aromatase inhibitor, is typically prescribed for postmenopausal women with breast cancer. This includes women who have stopped menstruating due to menopause, surgery, or chemotherapy.
Letclas Tablet, an aromatase inhibitor, lowers estrogen levels by blocking the aromatase enzyme. Since estrogen fuels the growth of certain breast cancers (termed "estrogen-dependent cancers"), this reduction can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue Letclas Tablet until tumor progression. Following tamoxifen or surgery, Letclas Tablet should be taken for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letclas Tablet followed by three years of tamoxifen may be used.
It's safe to take irbesartan and Letclas Tablet concurrently, but monitor your blood pressure closely as Letclas Tablet can elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letclas Tablet may cause cataracts. Report blurred vision or eye irritation to your doctor promptly.
Letclas Tablet may cause hot flushes, a common side effect resulting from decreased estrogen. These typically lessen as your body adapts, though some may experience them throughout treatment, subsiding months afterward. For persistent, bothersome hot flushes, consult your doctor.
While rare, Letclas Tablet may cause serious side effects such as stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letclas Tablet can weaken bones (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment to detect osteoporosis.
The Ministry of Health and Family Welfare restricts Letclas Tablet use to ovulation induction for anovulatory infertility.
Letclas Tablet
103
MRP 119
13% off